While potential Trump tariffs spark investor anxiety, a far more critical risk is unfolding in Asia. Are you prepared?

We take a look at 4 Pharma & Biotech companies whose share prices rallied in October on the back of positive announcements.

Whilst Zoom has made communicating with companies far more efficient, at NAOS we still believe that nothing beats a ...

Despite pressure on consumer spending, consumers prioritise trusted brands for their health-related needs and Haleon is a ...

There may not be industry-wide reporting just yet but transparency around returns and fees are finally coming through in ...

Australian investors have long favoured traditional assets, like stocks, bonds, and brick-and-mortar property.

And why Lazard Asset Management's June-Yon Kim believes investors can expect improving earnings growth from Japanese ...

The Fed’s November rate cut, though widely expected, sets a cautious tone as policymakers navigate a complex landscape under ...

Sometimes, the short sellers get it wrong. So, are there any opportunities among the most shorted ASX stocks? Find out in ...

Koda Capital's Chief Economist Brigette Leckie explains how moves in the global economy shape decisions for investors and ...

The outcome of the US presidential election certainly surprised many in the financial markets. These were the biggest moves ...

It's the Signal or Noise property show for 2024! The big questions may be the same but the answers are changing.